MICM
OYST

Matthews International Capital Management’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Matthews International Capital Management’s Portfolio OYST Stock Details OYST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-225,000
Closed -$6.5M – 43
2020
Q2 		$6.5M Hold
225,000
– – 0.51% 24
2020
Q1 		$7.88M Hold
225,000
– – 0.51% 22
2019
Q4 		$5.5M Buy
+225,000
New +$3.95M 0.26% 26

Other funds holding OYST

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KXA
KPCB XIV Associates Menlo Park, California $42.8M AUM 16.52% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

Matthews International Capital Management's OYST Position: Q3 2020 in Review

Matthews International Capital Management sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q3 2020, closing a stake of 225,000 shares — an estimated $6.5M sold.

Matthews International Capital Management first reported a position in OYST in Q4 2019 and held it in 3 quarters. The position peaked at $7.88M in Q1 2020. 66 funds tracked by Wall St. Rank hold OYST as of Q3 2020.

  • Matthews International Capital Management reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Matthews International Capital Management sold 225,000 Oyster Point Pharma, Inc. Common Stock shares in Q3 2020, an estimated $6.5M.
  • Matthews International Capital Management first reported a position in Oyster Point Pharma, Inc. Common Stock in Q4 2019 and held it in 3 quarters.
  • Matthews International Capital Management's Oyster Point Pharma, Inc. Common Stock position peaked at $7.88M in Q1 2020.
  • 66 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q3 2020.

Based on Matthews International Capital Management's 13F filing for Q3 2020, filed 5 Nov 2020.